Clinical Trials Browser

Phase 1/2 × Leukapheresis × 30 days × Clear all

NCT05672459 2026-02-25

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors

Phase 1/2 Active not recruiting

Kidney Neoplasms